Claim · SunVax SV-Delivery is complementary (not direct competitor) to therapeutic-developer in vivo CAR-T companies

SunVax SV-Delivery™ business model = enabling platform (R&D kit sales + partnership) · 与 EsoBiotec / Capstan / Interius / Orbital (therapeutic asset developers) 不在同一 P&L · 在 delivery technology 维度部分对标 但不直接客户竞争。SunVax 商业 angle = 卖 "shovels"(kits)给做 in vivo cell therapy 的多家客户 · 与单…

Type

claim

Domain

car-t

Grade

conference

License

LIGHT_HOPE_proprietary

evidence_grade

B

category

platform_positioning_claim

status

draft

instance_tag

sunvax-antibody-2025

claim_statement

SunVax SV-Delivery™ business model = enabling platform (R&D kit sales + partnership) · 与 EsoBiotec / Capstan / Interius / Orbital (therapeutic asset developers) 不在同一 P&L · 在 delivery technology 维度部分对标 但不直接客户竞争。SunVax 商业 angle = 卖 "shovels"(kits)给做 in vivo cell therapy 的多家客户 · 与单一

claim_evidence_grade

B

supporting_papers

m622-b5-paper-esobiotec-pr-2024-001

Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.